Advertisement

Advertisement

HK:2561 Stock Latest News

VISEN Pharmaceuticals Grants Performance-Linked Share Awards to Key Staff

Company AnnouncementsVISEN Pharmaceuticals Grants Performance-Linked Share Awards to Key Staff

VISEN Pharmaceuticals Shareholders Approve All AGM Resolutions and Expand Board

PremiumCompany Announcements

VISEN Pharmaceuticals Shareholders Approve All AGM Resolutions and Expand Board

1M ago

VISEN Pharmaceuticals Clarifies Board Structure and Committee Roles

PremiumCompany Announcements

VISEN Pharmaceuticals Clarifies Board Structure and Committee Roles

1M ago

VISEN Pharmaceuticals Adds New Director Appointments to AGM Agenda

PremiumCompany Announcements

VISEN Pharmaceuticals Adds New Director Appointments to AGM Agenda

2M ago

Visen Pharmaceuticals Sets 2026 AGM to Approve Directors, Auditor and Share Mandates

PremiumCompany Announcements

Visen Pharmaceuticals Sets 2026 AGM to Approve Directors, Auditor and Share Mandates

3M ago

VISEN Shareholders Clear Key Ascendis Licensing and Supply Deals

PremiumCompany AnnouncementsVISEN Shareholders Clear Key Ascendis Licensing and Supply Deals

3M ago

VISEN Pharmaceuticals Raises Caps on Connected Licensing and Supply Deals With Ascendis

Company Announcements

VISEN Pharmaceuticals Raises Caps on Connected Licensing and Supply Deals With Ascendis

4M ago

VISEN Pharmaceuticals Calls EGM to Approve Expanded Ascendis Licensing and Supply Deals

Company Announcements

VISEN Pharmaceuticals Calls EGM to Approve Expanded Ascendis Licensing and Supply Deals

4M ago

VISEN Deepens Losses as It Secures China Approval and Prepares to Launch Long-Acting Growth Hormone

PremiumCompany Announcements

VISEN Deepens Losses as It Secures China Approval and Prepares to Launch Long-Acting Growth Hormone

5M ago

VISEN Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results

PremiumCompany Announcements

VISEN Pharmaceuticals Sets March Board Meeting to Approve 2025 Annual Results

5M ago

VISEN Wins China Approval for Once-Weekly Growth Hormone Drug SKYTROFA

PremiumCompany Announcements

VISEN Wins China Approval for Once-Weekly Growth Hormone Drug SKYTROFA

6M ago

VISEN Pharmaceuticals Appoints New Chief Financial Officer

PremiumCompany Announcements

VISEN Pharmaceuticals Appoints New Chief Financial Officer

10M ago

VISEN Pharmaceuticals Amends Supply Agreement with Ascendis Europe

PremiumCompany AnnouncementsVISEN Pharmaceuticals Amends Supply Agreement with Ascendis Europe

11M ago

VISEN Pharmaceuticals Announces Board Composition and Committee Roles

Company Announcements

VISEN Pharmaceuticals Announces Board Composition and Committee Roles

11M ago

VISEN Pharmaceuticals Reports Interim Results and Advances Core Product

Company Announcements

VISEN Pharmaceuticals Reports Interim Results and Advances Core Product

11M ago

VISEN Pharmaceuticals Schedules Board Meeting for Interim Results Review

PremiumCompany Announcements

VISEN Pharmaceuticals Schedules Board Meeting for Interim Results Review

12M ago

VISEN Pharmaceuticals Announces AGM Results and Strategic Leadership Changes

PremiumCompany Announcements

VISEN Pharmaceuticals Announces AGM Results and Strategic Leadership Changes

1y ago

VISEN Pharmaceuticals Announces Supplemental Notice for AGM with Key Resolutions

PremiumCompany Announcements

VISEN Pharmaceuticals Announces Supplemental Notice for AGM with Key Resolutions

1y ago

VISEN Pharmaceuticals Secures Supply Chain with New Agreement

PremiumCompany Announcements

VISEN Pharmaceuticals Secures Supply Chain with New Agreement

1y ago

VISEN Pharmaceuticals Grants Award Shares to CEO

PremiumCompany AnnouncementsVISEN Pharmaceuticals Grants Award Shares to CEO

1y ago

VISEN Pharmaceuticals Announces 2025 Annual General Meeting and Key Resolutions

Company Announcements

VISEN Pharmaceuticals Announces 2025 Annual General Meeting and Key Resolutions

1y ago

VISEN Pharmaceuticals Concludes Stabilization Period and Confirms Compliance

Company Announcements

VISEN Pharmaceuticals Concludes Stabilization Period and Confirms Compliance

1y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >